This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.
The FDA’s issue with Hemp CBD stems from the FDCA’s “ Drug Exclusion Rule ” which, simply put, means that an article that has been approved or investigated as a drug cannot be a dietary supplement or be added to food unless the article was marketed as a supplement or food before it was investigated.
After years of delays, legal challenges, and obfuscation, the US Drug Enforcement Agency (DEA) finally announced that it would begin evaluating applications for federally-licensed research cannabis cultivators. . In 2019, a federal judge forced the DEA to explain its inaction.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. Leafly’s Ben Adlin documented the shockingly poor quality in this 2017 article : Smoking 25% THC, studying 8% THC. DEA finally relents.
The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. According to the data published in the DEA’s yearly Domestic Cannabis Eradication/Suppression Program Statistical Report, approximately 4.54
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Read the full article at [link].
While several lawmakers and industry stakeholders celebrated the announcement , not everyone on the cultivation side is so positive. This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. New Sampling Guidelines. What does this mean for hemp farmers?
Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. This new bill allows broad hemp cultivation.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
The DEA, which enforces the CSA, has indicated that it may consider delta-8 derived from hemp to be a “synthetically derived tetrahydrocannabinol” which still belongs on Schedule I of the CSA. Cultivation, transportation, and sale of unprocessed hemp in New York is governed by Article 29 of the Agriculture & Markets law.
“The results from our global studies show how effective broad-spectrum white light can be in improving crop performance for many cultivators around the world,” said Dr. David Hawley, principal scientist at Fluence. Broad-spectrum strategies are about balance and flexibility in the spectrum itself as well as the overall cultivation approach.
The DEA granted the University of Mississippi the exclusive right to grow legal research weed back in the 1960s, but this institution deliberately limits its plants to a maximum THC content of 8 percent. This spring, the DEA said it would finally start accepting applications for additional growers. . View original article.
We read, analyzed, summarized, and published several articles about it. I decided to take a more philosophical approach in this article and ask whether the Rule will initiate a crisis or create novel opportunities in the hemp industry. The USDA helpfully indicates that it will post directions for obtaining a DEA registration.
During the keynote session titled “Sue’n the DEA: The Story of a Cannabis Research Breakthrough,” Dr. Sisley—a pioneering medical cannabis researcher and volunteer medical director for more than 40 state cannabis licenses—will share her journey on navigating scientific and legal complexities of medical cannabis research. 24-26, 2021.
” The Drug Enforcement Administration’s (DEA) response to the 2018 Farm Bill is: “All synthetically derived tetrahydrocannabinols remain schedule 1 controlled substances.” View original article. “We’re not placing a judgment on that, whether it’s right to do that or not.
It remains to be seen whether the Drug Enforcement Authority, or DEA, will designate cannabis zones for these farmers. It is a firm believer in cultivating medical grade cannabis, employing aeroponics technique in laboratory glasshouses, and will not move to open fields until it is certain of the raw materials’ quality.
On February 14 th the Los Angeles Times published an article by Joe Mozingo entitled “Cannabis Farm Was a Model for California’s Legal Industry”. The article suggests the law enforcement officers who executed the search warrant were surprised by extent of the criminal activity at this “model” cannabis farm. WAKE UP CALIFORNIA! ,
MAPS has been trying to get approved for a cultivation license for almost 20 years and filed a lawsuit in December 2020 against the DEA. In the lawsuit, MAPS stated the DEA has failed to process more than 30 outstanding license applications for over 4 years despite administrative guidance. View original article.
Florida-based cannabis company Trulieve operates 77 dispensaries and roughly 2 million square feet of cultivation space in the Sunshine State, three dispensaries and 90,000 square feet of cultivation in Pennsylvania, and one dispensary in both California and Connecticut. Photo courtesy of Trulieve A TruPod cartridge from Trulieve.
Florida-based cannabis company Trulieve operates 77 dispensaries and roughly 2 million square feet of cultivation space in the Sunshine State, three dispensaries and 90,000 square feet of cultivation in Pennsylvania, and one dispensary in both California and Connecticut. Photo courtesy of Trulieve A TruPod cartridge from Trulieve.
Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. View original article. The post Legendary Cannabis Advocate Eddy Lepp Passes Away 1952-2021 appeared first on SpeedWeed.
All of these companies, the seeds banks, cultivators, manufacturers, grow shops, distributors, and online vendors operate in a grey market that permits them to sell their products as long as they follow some rules. They cannot sell any cannabis product with a tetrahydrocannabinol (THC) content higher than 0.2%
The bill will allow individuals over the age of 18 to possess up to 28 grams of flower, and cultivate up to six plants (or eight per household) for personal use. More than two years have passed since the Mexican Supreme Court declared that it was everyones’ constitutional right to consume and cultivate cannabis. .
Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. Unlike Marijuana , which is cultivated to yield psychoactive THC, Industrial Hemp yields more than 25,000 oil and fibrous products embraced by farmers as a hedge against lower-value soy, cotton, and alfalfa crops.
Later that year, Doblin sued the DEA for the first time. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies. submitted his first DEA application to manufacture marijuana for use in medical research. MAPS Founder Rick Doblin, Ph.D., Lyle Craker, Ph.D.,
Florida-based cannabis company Trulieve operates 77 dispensaries and roughly 2 million square feet of cultivation space in the Sunshine State, three dispensaries and 90,000 square feet of cultivation in Pennsylvania, and one dispensary in both California and Connecticut. Photo courtesy of Trulieve A TruPod cartridge from Trulieve.
Application: The Commerce Clause found in the Constitution under Article I, §8, clause 3, vests Congress the power to regulate interstate commerce. Filburn where the court held that Congress may regulate the intrastate cultivation of wheat because that activity in the aggregate would impose substantial effects on interstate commerce.
As detailed in our previous post , the MRTA required the CCB to “issue rules and regulations governing the home cultivation of cannabis by certified [medical marijuana] patients. And once the first cultivation regulations are released, it is only a matter of time before retailers come around. cannabinoid hemp and hemp extract.”
Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. View original article. Last year, the U.S. But I think it’s possible.”.
Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. View original article. By Paul Armentano. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition.
Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. Where cannabis cultivation and processing operations may operate is also subject to local (i.e., pursuant to Drug Enforcement Agency (DEA) or state-level programs).
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). As the cultivators prepare to launch operations, the first tripwire is immediately evident: Where will the cannabis come from? View original article. The Employees.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). As the cultivators prepare to launch operations, the first tripwire is immediately evident: Where will the cannabis come from? View original article. The Employees.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). As the cultivators prepare to launch operations, the first tripwire is immediately evident: Where will the cannabis come from? View original article. The Employees.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). As the cultivators prepare to launch operations, the first tripwire is immediately evident: Where will the cannabis come from? View original article. The Employees.
Rather than going head-to-head with other well-funded competitors in some US state auction while facing down the DEA or buying out a patient collective or two in Canada, the process was a bit simpler. This includes the cannabis development now afoot on at least several of the Channel Islands as well as several cultivations on the mainland.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). As the cultivators prepare to launch operations, the first tripwire is immediately evident: Where will the cannabis come from? View original article. The Employees.
As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. And even within that narrow scope, access is tightly limited: only eight DEA-registered bulk manufacturers are allowed to participate. In contrast, the U.S. marijuana policy permits only marijuana for research purposes.
A timeline of Florida’s battle for solid ground has been outlined in depth throughout my previous articles. They’ll learn about cultivation and extraction, but mostly from a ‘theoretical standpoint,’ says Mark Meade, chair of the college’s Biology, Health, and Wellness Department.”
And now the DEA just recently poked their head into that too, so I think there’s a lot of question marks for both cultivators and processors with respect to hemp. But I was curious, one thing that I hear a lot when we talk to folks on the hemp side is that there’s way too much cultivation going on and not enough processing.
Initiative 81 does the following: It makes the “investigation and arrest of adults for non-commercial planting, cultivating, purchasing, transporting, distributing, possessing, and/or engaging in practices with entheogenic plants and fungi among the Metropolitan Police Department’s lowest law enforcement priorities”; and.
Those of you beginning to pick up regulated cannabis clients might find this article a useful and interesting read. This article focuses on analyzing the guidance on this topic from the state boards of accountancy and Tax Court cases. As of October 21, 33 states and the District of Columbia have allowed the use of medical marijuana.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content